• 1
    Eriksson, B. & Schinazi, R.F. (1989) Combinations of 3′-azido-3′-deoxythimidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro. Antimicrobial Agents and Chemotherapy, 33, 663 669.
  • 2
    Jacobson, M.A., van der Horst, C., Causey, D.M., Dehlinger, M., Hafner, R., Mills, J. (1991) In vitro additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG protocol 053). Journal of Infectious Diseases, 153, 1219 1222.
  • 3
    Reddy, M.M., Grieco, M.H., McKinley, G.F., Causey, D.M., van der Horst, C.M., Parenti, D.M., Hooton, T.M., Davis, R.B., Jacobson, M.A. (1992) Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis. Journal of Infectious Diseases, 166, 607 610.
  • 4
    Studies of Ocular Complications of AIDS Research Group (1992) Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. New England Journal of Medicine, 326, 213 220.